After A 159.37% Jump This Year Is Iovance Biotherapeutics Inc (NASDAQ:IOVA) A Better Buy Than Others?
In recent trading session, Iovance Biotherapeutics Inc (NASDAQ:IOVA) saw 0.48 million shares changing hands at last check today with its beta currently measuring 0.61. Company’s